DAWN Stock Analysis: Buy, Sell, or Hold?
DAWN - Day One Biopharmaceuticals, Inc. Common Stock
$21.53
0.04 (0.19%)
▲
5d:
+0.28%
30d:
+0.8%
90d:
+78.38%
BUY
MODERATE Confidence
Analysis Updated: Apr 22, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When DAWN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: DAWN shows positive signals but monitor for confirmation. Market pricing in 0% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: DAWN shows positive signals but monitor for confirmation. Market pricing in 0% annual growth which appears achievable. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: DAWN is currently trading at $21.53, which is considered fair based on recent price action. From a valuation perspective, the stock is trading at a discount (Forward PE: -504.2) compared to its historical average (73.7). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, DAWN is in a strong uptrend. The price is currently testing key support at $21.45. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DAWN is in a strong uptrend. The price is currently testing key support at $21.45. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
59/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
67.6%
Protect Your Profits
DAWN is technically overbought (RSI 80). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- NEUTRAL: Near Wall St target ($21.50)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Support & Resistance Levels
Support Level
$21.45
Resistance Level
$21.53
Current Trend
Strong Uptrend
Technical data as of
Apr 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-504.22
Wall Street Target
$21.50
(-0.1%)
Revenue Growth (YoY)
83.9%
Profit Margin
-67.8%
PE vs Historical
-504.2 vs 73.7
CHEAP
Share & Embed Analysis
Last updated: June 23, 2026 9:22 PM ET
Data refreshes hourly during market hours. Next update: 10:22 PM
Data refreshes hourly during market hours. Next update: 10:22 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DAWN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Charles N York II
SELL
6065 shares
2026-02-17
Jeremy Bender
SELL
15459 shares
2026-02-17
Lauren Merendino
SELL
5814 shares
2026-02-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 56 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 57 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 67 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 61 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
Advanced DAWN Option Strategies
Professional options setups generated by AI based on today's DAWN price and gamma walls.
